IDYA logo

IDYA IDEAYA Biosciences, Inc.

NASDAQ Global Select · Biotechnology · Healthcare

$31.24
+0.59 (+1.92%)

IDEAYA Biosciences, Inc. is a precision oncology company primarily dedicated to identifying and advancing targeted therapies, particularly leveraging the concept of synthetic lethality. The firm aims to develop specific treatments for patient groups selected through molecular diagnostic methods. At the forefront of its clinical efforts are two investigational drugs. IDE397, a methionine adenosyltr…

Market Cap: $3.01Bwww.ideayabio.com

Price

No data yet.

Social Signal Score

50
5d
70
1 mentions
—
30d
42
5 mentions
—
60d
43
6 mentions
—
90d
46
9 mentions
—
news: 9

Analyst Ratings

26 analysts
Buyconsensus
Strong Buy 0Buy 24Hold 2Sell 0Strong Sell 0
Avg price target$53.2+70.3%
Low $44Median $57High $60
Current Consensus

Revenue

$10.24M
$0.00$69.28M$138.56M$207.83M
Mar 2018Sep 2026

Analyst Estimates

FY2025
$-1.29
$-1.54–$-0.78
12 analysts
FY2026
$-4.71
$-5.10–$-4.11
9 analysts
FY2027
$-4.36
$-5.16–$-2.31
11 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Yujiro S. Hata
Sector
Healthcare
Industry
Biotechnology
Employees
145
Beta
-0.09
Country
US
Piotroski score
1 / 9 (Weak)
Altman Z-score
12.95
www.ideayabio.com